Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Patent Granted for Treating Rheumatoid Arthritis

Photonics Spectra
Jan 2009
A US patent has been awarded to MorphoSys AG of Martinsried, Germany, and the University of Melbourne in Australia for use of antibodies against granulocyte-macrophage colony-stimulating factor. In 2007, the university granted MorphoSys an exclusive license for the patent family. The US patent will be used to treat the inflammation of rheumatoid arthritis by administering an antibody to patients that is directed against granulocyte-macrophage colony-stimulating factor.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to Photonics Spectra magazine - FREE!